267 related articles for article (PubMed ID: 7493617)
21. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
[TBL] [Abstract][Full Text] [Related]
22. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
23. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
Takemori AE; Portoghese PS
Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
[TBL] [Abstract][Full Text] [Related]
24. Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: effect of alpha 2-autoreceptor blockade.
Cosentino M; Marino F; Bombelli R; Ferrari M; Rasini E; Giaroni C; Lecchini S; Frigo G
Neurosci Lett; 1997 Jan; 222(2):75-8. PubMed ID: 9111732
[TBL] [Abstract][Full Text] [Related]
25. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
26. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
28. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
29. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
[TBL] [Abstract][Full Text] [Related]
30. The mu-opioid activity of kappa-opioid receptor agonist compounds in the guinea pig ileum.
Berzetei-Gurske IP; Toll L
Eur J Pharmacol; 1992 Mar; 212(2-3):283-6. PubMed ID: 1318215
[TBL] [Abstract][Full Text] [Related]
31. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
32. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
[TBL] [Abstract][Full Text] [Related]
33. Characterization of kappa-opioid receptors in the guinea-pig ileum.
Dissanayake VU; Hunter JC; Hill RG; Hughes J
Eur J Pharmacol; 1990 Jun; 182(1):73-82. PubMed ID: 2169427
[TBL] [Abstract][Full Text] [Related]
34. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
35. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.
Traynor JR; Corbett AD; Kosterlitz HW
Eur J Pharmacol; 1987 May; 137(1):85-9. PubMed ID: 3038579
[TBL] [Abstract][Full Text] [Related]
36. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
37. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
38. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.
Corbett AD; Kosterlitz HW
Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544
[TBL] [Abstract][Full Text] [Related]
39. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
40. Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity.
Friedmann T; Tóth Z; Hosztafi S; Simon CS; Makleit S; Fürst S
Arch Int Pharmacodyn Ther; 1994; 328(1):16-25. PubMed ID: 7893188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]